CellWell record HH-95281
Targeting the leptin-ghrelin axis for obesity management: Mechanistic insights and therapeutic approaches
Rajendiran M; Palani S; Subramaniyan V
Prostaglandins & other lipid mediators ยท 2026
In plain language
This narrative review reports that obesity involves elevated leptin with resistance alongside reduced, dysregulated ghrelin, and that leptin sensitizers and ghrelin antagonists remain experimental therapies requiring further clinical validation.
- Evidence
- Emerging
Cite this record: https://thecellwell.org/studies/HH-95281
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.